ETS1 and neoplasm: Ets-1 seems to be one of the most promising candidates, because targeting of this protein would possibly not only directly inhibit the proliferation and resistance to apoptosis of tumour cells, but also indirectly inhibit tumour growth and progression, including invasion and metastasis, through the inhibition of tumour angiogenesis [137].